determination of insulin-like growth factor-I in the monitoring of GH treatment with respect to effiicacy and side effects. Should potential risks of cardiovascular disease and cancer be considered?
Publikation: Bidrag til tidsskrift › Review › Forskning
Standard
determination of insulin-like growth factor-I in the monitoring of GH treatment with respect to effiicacy and side effects. Should potential risks of cardiovascular disease and cancer be considered? / Juul, Anders.
I: Hormone Research, Bind 51, 1999, s. 141-148.Publikation: Bidrag til tidsskrift › Review › Forskning
Harvard
Juul, A 1999, 'determination of insulin-like growth factor-I in the monitoring of GH treatment with respect to effiicacy and side effects. Should potential risks of cardiovascular disease and cancer be considered?', Hormone Research, bind 51, s. 141-148.
APA
Juul, A. (1999). determination of insulin-like growth factor-I in the monitoring of GH treatment with respect to effiicacy and side effects. Should potential risks of cardiovascular disease and cancer be considered? Hormone Research, 51, 141-148.
Vancouver
Juul A. determination of insulin-like growth factor-I in the monitoring of GH treatment with respect to effiicacy and side effects. Should potential risks of cardiovascular disease and cancer be considered? Hormone Research. 1999;51:141-148.
Author
Bibtex
@article{0a39b7138c314fcd8109000043f1a1c0,
title = "determination of insulin-like growth factor-I in the monitoring of GH treatment with respect to effiicacy and side effects. Should potential risks of cardiovascular disease and cancer be considered?",
author = "Anders Juul",
year = "1999",
language = "English",
volume = "51",
pages = "141--148",
journal = "Hormone Research",
issn = "0301-0163",
publisher = "S./Karger AG",
}
RIS
TY - JOUR
T1 - determination of insulin-like growth factor-I in the monitoring of GH treatment with respect to effiicacy and side effects. Should potential risks of cardiovascular disease and cancer be considered?
AU - Juul, Anders
PY - 1999
Y1 - 1999
M3 - Review
VL - 51
SP - 141
EP - 148
JO - Hormone Research
JF - Hormone Research
SN - 0301-0163
ER -
ID: 48484236